MMA Opposes Title Change for Physician Assistants

March 5, 2026

The MMA submitted a letter opposing SF 1084 (Kupec, DFL – Moorhead), which would change the statutory title of “physician assistant” to “physician associate.” The bill was heard in the Senate Health and Human Services Committee on March 4. 

The MMA believes that while physician assistants are valued members of physician-led care teams, changing their title raises significant concerns about patient understanding, transparency, and the integrity of Minnesota’s healthcare system.  

In its letter, the MMA argued that the term “associate” could suggest equivalency rather than collaboration under physician supervision, potentially misleading patients about credentials and scope of practice. 

The MMA’s position aligns with the AMA, which has cautioned that such changes could confuse patients and undermine transparency. Minnesota’s longstanding commitment to collaborative, physician-led care models prioritizes patient safety and quality outcomes. 

The bill was later held over for possible inclusion in a future omnibus bill. Its House companion, HF 88 (Reyer, DFL – Eagan), has yet to be heard in committee. 

Latest News

National Medical Specialty Societies Offer Vaccine Guidance

September 3, 2026

On September 2, the Vaccine Integrity Project (VIP) at the University of Minnesota’s Center for Infectious Disease Research and Policy, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, the American Academy of Family Physicians, and the Infectious Diseases Society of America issued guidelines recommending Americans continue to get immunized for influenza, COVID-19, and respiratory syncytial virus (RSV).   

Sanford Health and North Memorial Health Finalize Partnership

September 3, 2026

On September 1, Sanford Health and North Memorial Health announced that they had finalized their partnership, and are now one non-profit integrated health system operating as Sanford Health.  

State Releases Fact Sheet on Preparing for Patients Using Concentrated 7-OH Products

September 3, 2026

The Minnesota Department of Health (MDH), in collaboration with the MMA and partner physicians, has released an informational brief on concentrated 7‑hydroxymitragynine (7‑OH) and other kratom products, which are increasingly available in commercial forms such as tablets, gummies, liquids, and “enhanced” or “spiked” kratom products.